Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
CMPX Compass Therapeutics, Inc.	$151M	$0 0.0% of portfolio	0	Q3 2024 New
CGEN Compugen LTD	$122M	$0 0.0% of portfolio	0	Q3 2024 New
CNCE Concert Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
CNTB Connect Biopharma Holdings LTD	$55M	$0 0.0% of portfolio	0	Q3 2024 New
CNTX Context Therapeutics Inc.	$24.3M	$0 0.0% of portfolio	0	Q3 2024 New
CFRX Contrafect Corp	$1.18M	$0 0.0% of portfolio	0	Q3 2024 New
CRBP Corbus Pharmaceuticals Holdings, Inc.	$2.05B	$0 0.0% of portfolio	0	Q3 2024 New
CORT Corcept Therapeutics Inc	$6.16B	$0 0.0% of portfolio	0	Q3 2024 New
CRMD Cor Medix Inc.	$410M	$0 0.0% of portfolio	0	Q3 2024 New
CRTX Cortexyme, Inc.	$70.5M	$0 0.0% of portfolio	0	Q3 2024 New
CRVS Corvus Pharmaceuticals, Inc.	$379M	$0 0.0% of portfolio	0	Q3 2024 New
CRNX Crinetics Pharmaceuticals, Inc.	$3.01B	$0 0.0% of portfolio	0	Q3 2024 New
CUE Cue Biopharma, Inc.	$37.5M	$0 0.0% of portfolio	0	Q3 2024 New
CGEM Cullinan Oncology, Inc.	$572M	$0 0.0% of portfolio	0	Q3 2024 New
CVAC Cure Vac N.V.	$499M	$0 0.0% of portfolio	0	Q3 2024 New
CYCCP Cyclacel Pharmaceuticals, Inc.	$16.5M	$0 0.0% of portfolio	-	Q3 2024 New
CYTK Cytokinetics Inc	$4.62B	$0 0.0% of portfolio	1	Q3 2023 New
CTMX Cytom X Therapeutics, Inc.	$58.7M	$0 0.0% of portfolio	0	Q3 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$1.01B	$0 0.0% of portfolio	0	Q3 2024 New
DNLI Denali Therapeutics Inc.	$3.31B	$0 0.0% of portfolio	0	Q3 2024 New
DRMA Dermata Therapeutics, Inc.	$12.1M	$0 0.0% of portfolio	0	Q3 2024 New
DRMAW Dermata Therapeutics Inc Wt Ex	$0	$0 0.0% of portfolio	0	Q3 2024 New
DSGN Design Therapeutics, Inc.	$314M	$0 0.0% of portfolio	0	Q3 2024 New
DMAC Dia Medica Therapeutics Inc.	$118M	$0 0.0% of portfolio	0	Q3 2024 New
DYAI Dyadic International Inc	$48.3M	$0 0.0% of portfolio	0	Q3 2024 New
DYN Dyne Therapeutics, Inc.	$1.54B	$0 0.0% of portfolio	0	Q3 2024 New
EWTX Edgewise Therapeutics, Inc.	$2.03B	$0 0.0% of portfolio	0	Q3 2024 New
EDIT Editas Medicine, Inc.	$168M	$0 0.0% of portfolio	75	Q3 2023 Reduced 92.79%
ELDN Eledon Pharmaceuticals, Inc.	$53.2M	$0 0.0% of portfolio	0	Q3 2024 New
ELEV Elevation Oncology, Inc.	$13.7M	$0 0.0% of portfolio	0	Q3 2024 New
ELYM Eliem Therapeutics, Inc.	$109M	$0 0.0% of portfolio	0	Q3 2024 New
ENTA Enanta Pharmaceuticals Inc	$194M	$0 0.0% of portfolio	0	Q3 2024 New
ENLV Enlivex Therapeutics Ltd.	$16.2M	$0 0.0% of portfolio	0	Q3 2024 New
ENOB Enochian Biosciences Inc	$244M	$0 0.0% of portfolio	0	Q3 2024 New
ENTX Entera Bio Ltd.	$44.4M	$0 0.0% of portfolio	0	Q3 2024 New
TRDA Entrada Therapeutics, Inc.	$590M	$0 0.0% of portfolio	0	Q3 2024 New
EQ Equillium, Inc.	$24.4M	$0 0.0% of portfolio	0	Q3 2024 New
ERAS Erasca, Inc.	$330M	$0 0.0% of portfolio	0	Q3 2024 New
EPIX Essa Pharma Inc.	$80.7M	$0 0.0% of portfolio	0	Q3 2024 New
ETON Eton Pharmaceuticals, Inc.	$274M	$0 0.0% of portfolio	0	Q3 2024 New
EXAI Exscientia PLC	$593M	$0 0.0% of portfolio	0	Q3 2024 New
EYEN Eyenovia, Inc.	$3.76M	$0 0.0% of portfolio	0	Q3 2024 New
EYPT Eye Point Pharmaceuticals, Inc.	$305M	$0 0.0% of portfolio	0	Q3 2024 New
FSTX F Star Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q3 2024 New
FATE Fate Therapeutics Inc	$222M	$0 0.0% of portfolio	0	Q3 2024 New
FENC Fennec Pharmaceuticals Inc.	$139M	$0 0.0% of portfolio	0	Q3 2024 New
FGEN Fibrogen Inc	$37.5M	$0 0.0% of portfolio	0	Q3 2024 New
FWBI First Wave Bio Pharma, Inc.	$2.54M	$0 0.0% of portfolio	0	Q3 2024 New
FHTX Foghorn Therapeutics Inc.	$326M	$0 0.0% of portfolio	0	Q3 2024 New
FULC Fulcrum Therapeutics, Inc.	$169M	$0 0.0% of portfolio	0	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.